The company had posted a net profit of Rs 2.79 crore during the same period of previous fiscal.
Net sales of the company, rose to Rs 62.90 crore during the first quarter, as against Rs 54.72 crore during the same period of previous fiscal, RPG Life Sciences Ltd said in a filing to the BSE.
The company said it has received a notice of non-compliance from US Food and Drug Administration during the quarter.
"The company has duly responded to the said notice, however, there is no immediate business impact of this event as the company does not have any exports to USA," the Mumbai-based firm said.
Shares of the company today closed at Rs 65.50 apiece on the BSE, up 1.55% from their previous close.